ResearcherHuzhou Normal UniversityNo recent work listed

Wenming Feng

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5100525668. Sources: OpenAlex.

Their work

Papers: 2 (first author 1, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2022: 1 paper · 2023: 1 paper

Papers 2

Comment on ‘Inflammatory biomarkers and nanotechnology: new insights in pancreatic cancer early detection’ First author DOI 10.1097/js9.0000000000000655 ↗
The Biocomplex Assembled from Antigen Peptide and Toll-like Receptor Agonist Improved the Immunity against Pancreatic Adenocarcinoma In Vivo. Co-author DOI 10.1155/2022/2965496 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yao Wang · 1 shared paper, 2023 · strength 0.31
- Paper Comment on ‘Inflammatory biomarkers and nanotechnology: new insights in pancreatic cancer early detection’ DOI 10.1097/js9.0000000000000655 ↗
Chengwu Tang · 1 shared paper, 2023 · strength 0.31
- Paper Comment on ‘Inflammatory biomarkers and nanotechnology: new insights in pancreatic cancer early detection’ DOI 10.1097/js9.0000000000000655 ↗
Tao Xue · 1 shared paper, 2022 · strength 0.19
- Paper The Biocomplex Assembled from Antigen Peptide and Toll-like Receptor Agonist Improved the Immunity against Pancreatic A… DOI 10.1155/2022/2965496 ↗
Ge Cui · 1 shared paper, 2022 · strength 0.19
- Paper The Biocomplex Assembled from Antigen Peptide and Toll-like Receptor Agonist Improved the Immunity against Pancreatic A… DOI 10.1155/2022/2965496 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.